Immunic to implement 1-for-10 reverse stock split [Yahoo! Finance]
Immunic, Inc. (IMUX)
Company Research
Source: Yahoo! Finance
Immunic Inc (NASDAQ:IMUX, FRA:10VA) announced it will implement a 1-for-10 reverse stock split of its common shares, effective April 27, as part of efforts to meet contractual obligations tied to a recent securities agreement. The reverse split will take effect at 12:01 a.m. Eastern Time, with the company's shares continuing to trade on the Nasdaq Capital Market under the ticker symbol “IMUX.” Trading on a split-adjusted basis is set to begin at market open the same day. The decision follows approval from shareholders at a special meeting held on April 14, where investors authorized a reverse split ratio ranging from 1-for-10 to 1-for-30. The company's board of directors subsequently selected the 1-for-10 ratio. Under the terms of the split, every ten existing shares will be consolidated into one share. As a result, the number of outstanding shares is expected to decrease from approximately 136 million to about 13.6 million. The total number of authorized shares and the stock's
Show less
Read more
Impact Snapshot
Event Time:
IMUX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMUX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMUX alerts
High impacting Immunic, Inc. news events
Weekly update
A roundup of the hottest topics
IMUX
News
- Immunic appoints Michael Panzara as CMO ahead of pivotal MS drug readout [Yahoo! Finance]Yahoo! Finance
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer [TheStreet.com]TheStreet.com
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical OfficerPR Newswire
- Immunic announces 1-for-10 reverse stock split [Seeking Alpha]Seeking Alpha
IMUX
Earnings
- 11/13/25 - Beat
IMUX
Sec Filings
- 4/29/26 - Form 4
- 4/29/26 - Form 3
- 4/28/26 - Form 8-K
- IMUX's page on the SEC website